Mitochondrial Disease Therapeutics Market Size, Share & Industry Analysis, By Drug Class (Mitochondrial Membrane Stabilizers, Electron Transport Chain Modulators, Redox Modulators), By Product (Elamipretide, Idebenone, Coenzyme Q10/Ubiquinol, Taurine), By Disease Indication (Primary Mitochondrial Myopathy, MELAS, and Leber Hereditary Optic Neuropathy), By Treatment Intent (Disease Modification, Chronic Metabolic Support, and Acute Crisis Management), By Route of Administration (Oral, Subcutaneous, and Intravenous), By Age Group (Pediatric and Adults), and Regional Forecast, 2026-2034